The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
The New England Journal of Medicine, 376, 16, pp. 1527-1539 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (16), pp.1527-1539. ⟨10.1056/NEJMoa1701488⟩ New England Journal of Medicine, 376(16), 1527-1539. MASSACHUSETTS MEDICAL SOCIETY New England Journal of Medicine, 376(16), 1527. Massachussetts Medical Society The New England Journal of Medicine, 376, 1527-1539 Department of Medicine Publications Ridker, P M, Revkin, J, Amarenco, P, Brunell, R, Curto, M, Civeira, F, Flather, M, Glynn, R J, Gregoire, J, Jukema, J W, Karpov, Y, Kastelein, J J P, Koenig, W, Lorenzatti, A, Manga, P, Masiukiewicz, U, Miller, M, Mosterd, A, Murin, J, Nicolau, J C, Nissen, S, Ponikowski, P, Santos, R D, Schwartz, P F, Soran, H, White, H, Wright, R S, Vrablik, M, Yunis, C, Shear, C L, Tardif, J-C, SPIRE Cardiovascular Outcome Investigators & Michael Jepsen, J 2017, ' Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients ', The New England Journal of Medicine, vol. 376, no. 16, pp. 1527-1539 . https://doi.org/10.1056/NEJMoa1701488 New England Journal of Medicine, 376(16), 1527-1539 Zaguán. Repositorio Digital de la Universidad de Zaragoza instname New England journal of medicine, 376(16), 1527-1539. Massachussetts Medical Society
The New England journal of medicine, vol. 372, no. 25, pp. 2387-2397 Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP Cannon, C P, Blazing, M A, Giugliano, R P, McCagg, A, White, J A, Theroux, P, Darius, H, Lewis, B S, Ophuis, T O, Jukema, J W, De Ferrari, G M, Ruzyllo, W, De Lucca, P, Im, K, Bohula, E A, Reist, C, Wiviott, S D, Tershakovec, A M, Musliner, T A, Braunwald, E, Califf, R M, IMPROVE-IT Investigators & Clemmensen, P M 2015, ' Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes ', The New England Journal of Medicine, vol. 372, no. 25, pp. 2387-2397 . https://doi.org/10.1056/NEJMoa1410489 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (25), pp.2387-97. ⟨10.1056/NEJMoa1410489⟩ New England Journal of Medicine, 372(25), 2387-2397 New England journal of medicine, 372(25), 2387-2397. Massachussetts Medical Society
The New England Journal of Medicine, 366, 20-33 Tricoci, P, Huang, Z, Held, C, Moliterno, D J, Armstrong, P W, Van de Werf, F, White, H D, Aylward, P E, Wallentin, L, Chen, E, Lokhnygina, Y, Pei, J, Leonardi, S, Rorick, T L, Kilian, A M, Jennings, L H K, Ambrosio, G, Bode, C, Cequier, A, Cornel, J H, Diaz, R, Erkan, A, Huber, K, Hudson, M P, Jiang, L, Jukema, J W, Lewis, B S, Lincoff, A M, Montalescot, G, Nicolau, J C, Ogawa, H, Pfisterer, M, Prieto, J C, Ruzyllo, W, Sinnaeve, P R, Storey, R F, Valgimigli, M, Whellan, D J, Widimsky, P, Strony, J, Harrington, R A, Mahaffey, K W, TRACER Investigators & Rasmussen, L H 2012, ' Thrombin-receptor antagonist vorapaxar in acute coronary syndromes ', The New England Journal of Medicine, vol. 366, no. 1, pp. 20-33 . https://doi.org/10.1056/NEJMoa1109719 Recercat. Dipósit de la Recerca de Catalunya instname Dipòsit Digital de la UB Universidad de Barcelona The New England Journal of Medicine, 366, 1, pp. 20-33